Back to search
FDAFDA · Food and drugs·Recall number Z-2293-2016

MOSAIQ Oncology Information System

Published August 3, 2016 · Recall initiated: July 15, 2016

Summary

FDA records medical device Class II recall Z-2293-2016, published August 3, 2016 and initiated July 15, 2016. Recalling firm: Elekta, Inc.; Status: Ongoing; Reported quantity: 383; Lot: Versions 2.50.05 and higher. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

It is possible that a change to an Order Set will not be saved in the current open Care Plan. This can result in a wrong chemo dose in the order.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Elekta, Inc.
Distributor
Worldwide distribution. US nationwide, Antigua and Barbuda, Australia, Austria, Bahamas, Bahrain, Canada, Czech Republic, Germany, Hungary, South Africa, Spain, Sweden, Turkey, and United Kingdom
Lot
Versions 2.50.05 and higher
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MOSAIQ Oncology Information System recalled?

Yes. FDA published recall Z-2293-2016 on August 3, 2016. Reported hazard: It is possible that a change to an Order Set will not be saved in the current open Care Plan. This can result in a wrong chemo dose in the order.

What should I do if I have this product?

Voluntary: Firm initiated · Letter